| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |